Hypertrophic obstructive cardiomypathy in liver transplant patients

Cardiovascular Diseases and Liver Transplantation

Volumn , Issue , 2011, Pages 99-111

  Bravo, Paco E ^a   Hage, Fadi G ^b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868117822     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (34)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J. Am. Coll.Cardiol. 2003; 42(9):1687-713.
2. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N. Engl. J. Med. 2003 23;348(4):295-303.
3. Sellke, FW. Sabiston and Spencer's Surgery of the Chest. 8th Edition. Philadelphia: Saunders Elsevier 2009.
4. Hage FG; Aqel R, Aljaroudi W, Heo J, Pothineni K, Hansalia S, et al. Correlation between serum cardiac markers and myocardial infarct size quantified by myocardial perfusion imaging in patients with hypertrophic cardiomyopathy after alcohol septal ablation. The American Journal of Cardiology 2010;105(2):261-6.
5. Aqel RA, Hage FG, Cogar B, Burri M, Wells B, Allison S, et al. Trans-thoracic echocardiography guided procedures in the catheterization laboratory. Echocardiography 2007; 24(9):1000-7.
6. Libby P. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th Edition. Philadelphia: Saunders Elsevier; 2007.
7. Maron., BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2004 16;44(10):2044-53.
8. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 22:346(8969):211-4.
9. Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J. Interv. Cardio 2006; 19(4):319-27.
10. Fernandes VL, Nielsen C, Nagueh SF, Herrin AE, Slifka C, Franklin J et al. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. JACC Cardiovasc Interv 2008;1(5):561-70.
11. Kwon DH, Kapadia SR, Tuzcu EM, Halley CM, Gorodeski EZ, Curtin RJ, et al. Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation. JACC Cardiovasc. Interv.2008; 1(4):432-8.
12. Agarwal S, Tuzcu EM, Desai MY, Smedira N, Lever HM, Lytle BW, et al. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. J. Am. Coll. Cardiol.2010; 23;55(8):823-34.
13. Hage FG, Karakus G, Luke WD, Jr,; Suwanjutah T, Burri MV, Nanda NC et al. Effect of alcohol-induced septal ablation on left atrial volume and ejection fraction assessed by real time three-dimensional trans-thoracic echocardiography in patients with hypertrophic cardiomyopathy. Echocardiography 2008;25(7):784-9.
14. Aqel RA, Hage FG, Zohgbi GJ, Tabereaux PB, Lawson D, Heo J et al. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients. Am. J. Cardiol.2008;101(9):1328-33.
15. Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J. Am. Coll. Cardiol. 1997;29(2):435-41.
16. Fananapazir L; Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90(6):2731-42.
17. Thompson RC, Liberthson RR, Lowenstein E. Perioperative anesthetic risk of noncardiac surgery in hypertrophic obstructive cardiomyopathy. JAMA 1985;254(17):2419-21.
18. Haering JM, Comunale ME, Parker RA, Lowenstein E, Douglas PS, Krumholz HM et al. Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy. Anesthesiology 1996;85(2):254-9.
19. Chang, KH, Sano E, Saitoh Y, Hanaoka K. Anesthetic management of patients with hypertrophic obstructive cardiomyopathy undergoing non-cardiac surgery. Masui 2004;53(8):934-42.
20. Lim YC, Doblar DD, Frenette L, Fan PH, Poplawski S, Nanda NC. Intraoperative transesophageal echocardiography in orthotopic liver transplantation in a patient with hypertrophic cardiomyopathy. J Clin Anesth 1995;7(3):245-9.
21. Harley ID, Jones EF, Liu G, McCall PR, McNicol PL. Orthotopic liver transplantation in two patients with hypertrophic obstructive cardiomyopathy. Br. J. Anaesth. 1996;77(5):675-7.
22. Paramesh AS, Fairchild RB, Quinn TM, Leya F, George M, Van Thiel DH. Amelioration of hypertrophic cardiomyopathy using nonsurgical septal ablation in a cirrhotic patient prior to liver transplantation. Liver Transpl 2005;11(2):236-8.
23. Cywinski JB, Argalious M, Marks TN, Parker BM. Dynamic left ventricular outflow tract obstruction in an orthotopic liver transplant recipient. Liver Transp. 2005;11 (6):692-5.
24. Chin JH, Kim YK, Choi DK, Shin WJ, Hwang GS. Aggravation of mitral regurgitation by calcium administration in a patient with hypertrophic cardiomyopathy during liver transplantation: a case report. Transplant. Proc.20809;41(5):1979-81.
25. Hage FG, Bravo PE, Zoghbi GJ, Bynon JS, Aqel RA. Hypertrophic obstructive cardiomyopathy in liver transplant patients. Cardiol. J.2008;15(1):74-9.
26. Hayashida N, Shoujima T, Teshima H, Yokokura Y, Takagi K, Tomoeda H et al. Clinical outcome after cardiac operations in patients with cirrhosis. Ann. Thorac. Surg. 2004;77(2):500-5.
27. Suman A, Barnes DS, Zein NN, Levinthal GN, Connor JT, Carey WD. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin. Gastroenterol. Hepatol..2004;2(8):719-23.
28. Cregg N, Cheng DC, Karski JM, Williams WG, Webb G, Wigle ED. Morbidity outcome in patients with hypertrophic obstructive cardiomyopathy undergoing cardiac septal myectomy: early-extubation anesthesia versus high-dose opioid anesthesia technique. J. Cardiothorac. Vasc. Anesth.1999;13(1):47-52.
29. Matthews, T; Dickinson JE. Considerations for delivery in pregnancies complicated by maternal hypertrophic obstructive cardiomyopathy. Aust. N Z J. Obstet. Gynaecology 2005;45(6):526-8.
30. Pitton MA, Petolillo M, Munegato E, Ciccarese AA, Visentin S, Paternoster DM. Hypertrophic obstructive cardiomyopathy and pregnancy: anesthesiological observations and clinical series. Minerva Anestesiol.2007;73(5):313-8.
31. Suriani RJ, Cutrone A, Feierman D, Konstadt S. Intraoperative transesophageal echocardiography during liver transplantation. J. Cardiothorac. Vasc. Anesth. 1996;10(6):699-707.
32. Miller, RD. Miller's Anesthesia. 7th Edition. Churchill Livingstone. 2009.
33. Aggarwal S, Kang Y, Freeman JA, Fortunato FL Jr., Pinsky MR. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J. Crit. Care 1993; 8(3):154-60.
34. Popescu WM, Perrino AC, Jr. Critical cardiac decompensation during laparoscopic surgery. J. Am. Soc. Echocardiogr.2006;19(8):1074 e5-6.